BR0010693A - Azaindole derivatives for treating depression - Google Patents
Azaindole derivatives for treating depressionInfo
- Publication number
- BR0010693A BR0010693A BR0010693-3A BR0010693A BR0010693A BR 0010693 A BR0010693 A BR 0010693A BR 0010693 A BR0010693 A BR 0010693A BR 0010693 A BR0010693 A BR 0010693A
- Authority
- BR
- Brazil
- Prior art keywords
- treating depression
- azaindole derivatives
- depression
- affected
- ring
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
Abstract
Patente de Invenção: "DERIVADOS AZAINDOL PARA TRATAMENTO DE DEPRESSãO". Compostos úteis no tratamento de doenças afetadas por desordens dos sistemas neurológicos afetados - serotonina, tais como depressão e ansiedade, são providos tendo a fórmula (1) onde: R~ 1~ e R~ 2~ formam um anel carbocíclico ou heterocíclico de 5 a 7 átomos, onde o dito anel pode ser saturado ou insaturado; e X é independentemente hidrogênio, ciano, carbamoíla, halogênio ou alcóxi; ou seus sais farmaceuticamente aceitáveis.Invention Patent: "AZAINDOL DERIVATIVES FOR TREATING DEPRESSION". Compounds useful in the treatment of diseases affected by disorders of the affected neurological systems - serotonin, such as depression and anxiety, are provided having the formula (1) where: R ~ 1 ~ and R ~ 2 ~ form a 5 to a carbocyclic or heterocyclic ring 7 atoms, where said ring can be saturated or unsaturated; and X is independently hydrogen, cyano, carbamoyl, halogen or alkoxy; or their pharmaceutically acceptable salts.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US29673699A | 1999-04-22 | 1999-04-22 | |
PCT/US2000/010628 WO2000064898A1 (en) | 1999-04-22 | 2000-04-20 | Azaindole derivatives for the treatment of depression |
Publications (1)
Publication Number | Publication Date |
---|---|
BR0010693A true BR0010693A (en) | 2002-02-05 |
Family
ID=23143341
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0010693-3A BR0010693A (en) | 1999-04-22 | 2000-04-20 | Azaindole derivatives for treating depression |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP1171439A1 (en) |
JP (1) | JP2002543079A (en) |
CN (1) | CN1348451A (en) |
AR (1) | AR028475A1 (en) |
AU (1) | AU4364400A (en) |
BR (1) | BR0010693A (en) |
CA (1) | CA2367681A1 (en) |
WO (1) | WO2000064898A1 (en) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100338062C (en) * | 2002-03-28 | 2007-09-19 | 卫材株式会社 | Azaindoles as inhibitors of c-Jun N-terminal kinases |
JP2008521771A (en) | 2004-11-26 | 2008-06-26 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | Isoxazoline-indole derivatives having improved antipsychotic and anxiolytic activity |
WO2008063888A2 (en) | 2006-11-22 | 2008-05-29 | Plexxikon, Inc. | Compounds modulating c-fms and/or c-kit activity and uses therefor |
US20100190777A1 (en) | 2007-07-17 | 2010-07-29 | Plexxikon Inc. | Compounds and methods for kinase modulation, and indications therefor |
CR20170089A (en) | 2009-04-03 | 2017-07-17 | Plexxikon Inc | PROPANE-ACID COMPOSITIONS-1 - SULFONIC {3- [5- (4-CHLORINE-PHENYL) -1H-PIRROLO [2,3-B] PIRIDINA-3-CARBONIL] -2,4-DIFLUORO-PHENIL} -AMIDA AND THE USE OF THE SAME |
RS57869B1 (en) | 2009-06-17 | 2018-12-31 | Vertex Pharma | Inhibitors of influenza viruses replication |
NZ599866A (en) | 2009-11-06 | 2014-09-26 | Plexxikon Inc | Compounds and methods for kinase modulation, and indications therefor |
KR20140014110A (en) | 2010-12-16 | 2014-02-05 | 버텍스 파마슈티칼스 인코포레이티드 | Inhibitors of influenza viruses replication |
MA34948B1 (en) | 2011-02-07 | 2014-03-01 | Plexxikon Inc | COMPOUNDS AND METHODS FOR MODULATING KINASE, AND INDICATIONS THEREOF |
TWI558702B (en) | 2011-02-21 | 2016-11-21 | 普雷辛肯公司 | Solid forms of a pharmaceutically active substance |
UA118010C2 (en) | 2011-08-01 | 2018-11-12 | Вертекс Фармасьютікалз Інкорпорейтед | INFLUENCES OF INFLUENZA VIRUS REPLICATION |
US9150570B2 (en) | 2012-05-31 | 2015-10-06 | Plexxikon Inc. | Synthesis of heterocyclic compounds |
JP6615755B2 (en) | 2013-11-13 | 2019-12-04 | バーテックス ファーマシューティカルズ インコーポレイテッド | Inhibitors of influenza virus replication |
SI3068782T1 (en) | 2013-11-13 | 2018-10-30 | Vertex Pharmaceuticals Incorporated | Methods of preparing inhibitors of influenza viruses replication |
EP3294717B1 (en) | 2015-05-13 | 2020-07-29 | Vertex Pharmaceuticals Inc. | Methods of preparing inhibitors of influenza viruses replication |
JP6857617B2 (en) | 2015-05-13 | 2021-04-14 | バーテックス ファーマシューティカルズ インコーポレイテッドVertex Pharmaceuticals Incorporated | Influenza virus replication inhibitor |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5521197A (en) * | 1994-12-01 | 1996-05-28 | Eli Lilly And Company | 3-<1-alkylenearyl>-4-<1,2,3,6-tetrahydropyridinyl>-and 3-<1-alkylenearyl>-4-piperidinyl-1h-indoles: new 5-HT1F agonists |
US5627196A (en) * | 1995-01-17 | 1997-05-06 | Eli Lilly And Company | Compounds having effects on serotonin-related systems |
US5576321A (en) * | 1995-01-17 | 1996-11-19 | Eli Lilly And Company | Compounds having effects on serotonin-related systems |
-
2000
- 2000-04-19 AR ARP000101879A patent/AR028475A1/en unknown
- 2000-04-20 CA CA002367681A patent/CA2367681A1/en not_active Abandoned
- 2000-04-20 JP JP2000614250A patent/JP2002543079A/en active Pending
- 2000-04-20 CN CN00806589A patent/CN1348451A/en active Pending
- 2000-04-20 WO PCT/US2000/010628 patent/WO2000064898A1/en not_active Application Discontinuation
- 2000-04-20 AU AU43644/00A patent/AU4364400A/en not_active Abandoned
- 2000-04-20 EP EP00923540A patent/EP1171439A1/en not_active Withdrawn
- 2000-04-20 BR BR0010693-3A patent/BR0010693A/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
JP2002543079A (en) | 2002-12-17 |
AR028475A1 (en) | 2003-05-14 |
CN1348451A (en) | 2002-05-08 |
AU4364400A (en) | 2000-11-10 |
CA2367681A1 (en) | 2000-11-02 |
EP1171439A1 (en) | 2002-01-16 |
WO2000064898A1 (en) | 2000-11-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR0010693A (en) | Azaindole derivatives for treating depression | |
ATE370138T1 (en) | NEW IMIDAZOPYRIDINES AND THEIR USE | |
BRPI0314308B8 (en) | opioid antagonists, their uses, and pharmaceutical composition | |
BR0108610A (en) | Azapolycyclic compounds condensed with aryl | |
TR200201505T2 (en) | Pirazolopyrimidines as therapeutic agents | |
BR0113448A (en) | A compound of the formula or a salt or solvate thereof or a physiologically functional derivative thereof, pharmaceutical composition, use of the compound or a salt or solvate thereof or a physiologically functional derivative thereof, and methods for treating a disease-mediated condition or condition. p38 kinase or cytokine-mediated, and jnk kinase-mediated or cytokine-mediated, and, to treat two or more conditions or diseases independently mediated by p38 and jnk kinase activity | |
ES2161418T3 (en) | PIRIDILFURAN AND PIRIDILTIOFENO COMPOUNDS AND PHARMACEUTICAL USE OF THEM. | |
MXPA04012965A (en) | Viral inhibitors. | |
BR0311541A (en) | indole, azaindole and 4-akenyl piperidine related heterocyclic amides | |
BR0312232A (en) | Caspase inhibitors and their uses | |
ES2158778B1 (en) | PAROXETINE SALT COMPOUNDS, THEIR PREPARATION AND USE, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM. | |
NO20072046L (en) | Halogen-substituted benzodiazepine derivatives | |
BR9914040A (en) | Derivatives of [1,2,4] triazolo [1,5-c] pyrimidine and its use, medication, antagonist, agent for preventing or treating diseases, as well as a process for preventing or treating disorders | |
DE60305514D1 (en) | NEW USE OF BENZOTHIAZONE DERIVATIVES | |
NO990433L (en) | New compounds and compositions for the treatment of diseases associated with tryptase activity | |
BR0315777A (en) | Use of piperazine derivatives as ccr1 antagonists | |
ATE242246T1 (en) | (1,2,3)-TRIAZOLO(4,5-D)PYRIMIDINE DERIVATIVES AS ANTITHRBOTIC AGENTS | |
WO2002079169A8 (en) | Cyano-substituted dihydropyrimidine compounds and their use to treat diseases | |
BR9807950A (en) | Compound, pharmaceutical composition, use of a compound, and, processes to treat or reduce the risk of human diseases or conditions, the risk of inflammatory disease, the risk of pain and for the preparation of a compound | |
WO2002079149A3 (en) | Novel cyano-substituted dihydropyrimidine compounds and their use to treat diseases | |
MXPA01007940A (en) | Azabicycloalkane derivatives and therapeutic uses thereof. | |
BR0213417A (en) | Tetracycliczaindoles and indolines compounds and compositions having 5-ht activity and their uses | |
ATE389655T1 (en) | PYRIMIDINE DERIVATIVES | |
ATE482211T1 (en) | IMIDAZOÄ1,2-AÜPYRIDINE ANXIOLYTICS | |
FR2767527B1 (en) | INDOLIC PIPERAZINE DERIVATIVES USEFUL AS MEDICAMENTS AND PREPARATION METHOD |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA10 | Dismissal: dismissal - article 33 of industrial property law | ||
B11Y | Definitive dismissal acc. article 33 of ipl - extension of time limit for request of examination expired | ||
B25D | Requested change of name of applicant approved |